nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminocaproic Acid—AOX1—Methotrexate—testicular cancer	0.405	1	CbGbCtD
Aminocaproic Acid—PLG—vein—testicular cancer	0.13	0.465	CbGeAlD
Aminocaproic Acid—PLG—embryo—testicular cancer	0.0247	0.0879	CbGeAlD
Aminocaproic Acid—PLAT—seminal vesicle—testicular cancer	0.0197	0.0702	CbGeAlD
Aminocaproic Acid—PLG—gonad—testicular cancer	0.0168	0.0597	CbGeAlD
Aminocaproic Acid—PLG—female gonad—testicular cancer	0.0136	0.0485	CbGeAlD
Aminocaproic Acid—PLG—testis—testicular cancer	0.0121	0.043	CbGeAlD
Aminocaproic Acid—PLAT—female gonad—testicular cancer	0.0116	0.0412	CbGeAlD
Aminocaproic Acid—AOX1—seminal vesicle—testicular cancer	0.0107	0.0379	CbGeAlD
Aminocaproic Acid—PLAT—testis—testicular cancer	0.0103	0.0366	CbGeAlD
Aminocaproic Acid—AOX1—gonad—testicular cancer	0.0077	0.0274	CbGeAlD
Aminocaproic Acid—PLAT—lymph node—testicular cancer	0.00744	0.0265	CbGeAlD
Aminocaproic Acid—AOX1—female gonad—testicular cancer	0.00625	0.0223	CbGeAlD
Aminocaproic Acid—AOX1—testis—testicular cancer	0.00555	0.0198	CbGeAlD
Aminocaproic Acid—AOX1—lymph node—testicular cancer	0.00402	0.0143	CbGeAlD
Aminocaproic Acid—PLAT—NOTCH1 regulation of human endothelial cell calcification—FGFR3—testicular cancer	0.00245	0.155	CbGpPWpGaD
Aminocaproic Acid—PLG—Regulation of IGF Activity by IGFBP—MMP2—testicular cancer	0.00169	0.106	CbGpPWpGaD
Aminocaproic Acid—Agranulocytosis—Ifosfamide—testicular cancer	0.0016	0.00537	CcSEcCtD
Aminocaproic Acid—Necrosis—Doxorubicin—testicular cancer	0.0016	0.00537	CcSEcCtD
Aminocaproic Acid—Delirium—Epirubicin—testicular cancer	0.00158	0.0053	CcSEcCtD
Aminocaproic Acid—Bradycardia—Ifosfamide—testicular cancer	0.00157	0.00526	CcSEcCtD
Aminocaproic Acid—Discomfort—Vinblastine—testicular cancer	0.00157	0.00524	CcSEcCtD
Aminocaproic Acid—Hallucination—Ifosfamide—testicular cancer	0.00154	0.00514	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Vinblastine—testicular cancer	0.00149	0.00498	CcSEcCtD
Aminocaproic Acid—Lacrimation increased—Epirubicin—testicular cancer	0.00148	0.00494	CcSEcCtD
Aminocaproic Acid—Delirium—Doxorubicin—testicular cancer	0.00146	0.0049	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Bleomycin—testicular cancer	0.00146	0.00488	CcSEcCtD
Aminocaproic Acid—Renal failure—Cisplatin—testicular cancer	0.00146	0.00488	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Methotrexate—testicular cancer	0.00145	0.00487	CcSEcCtD
Aminocaproic Acid—Tinnitus—Ifosfamide—testicular cancer	0.00144	0.00482	CcSEcCtD
Aminocaproic Acid—Malaise—Bleomycin—testicular cancer	0.00142	0.00475	CcSEcCtD
Aminocaproic Acid—Pain—Chlorambucil—testicular cancer	0.00142	0.00475	CcSEcCtD
Aminocaproic Acid—Leukopenia—Bleomycin—testicular cancer	0.00141	0.00471	CcSEcCtD
Aminocaproic Acid—Lacrimation increased—Doxorubicin—testicular cancer	0.00137	0.00457	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Chlorambucil—testicular cancer	0.00137	0.00457	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Epirubicin—testicular cancer	0.00136	0.00456	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Dactinomycin—testicular cancer	0.00136	0.00455	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00136	0.00454	CcSEcCtD
Aminocaproic Acid—Bradycardia—Cisplatin—testicular cancer	0.00135	0.00453	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Epirubicin—testicular cancer	0.00135	0.00453	CcSEcCtD
Aminocaproic Acid—Myalgia—Bleomycin—testicular cancer	0.00134	0.00448	CcSEcCtD
Aminocaproic Acid—Renal failure—Etoposide—testicular cancer	0.00134	0.00447	CcSEcCtD
Aminocaproic Acid—Discomfort—Bleomycin—testicular cancer	0.00132	0.00443	CcSEcCtD
Aminocaproic Acid—Malaise—Dactinomycin—testicular cancer	0.00132	0.00443	CcSEcCtD
Aminocaproic Acid—Leukopenia—Dactinomycin—testicular cancer	0.00131	0.00439	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Chlorambucil—testicular cancer	0.00131	0.00439	CcSEcCtD
Aminocaproic Acid—Pain—Vinblastine—testicular cancer	0.0013	0.00435	CcSEcCtD
Aminocaproic Acid—Confusional state—Bleomycin—testicular cancer	0.00129	0.00433	CcSEcCtD
Aminocaproic Acid—Blood urea increased—Epirubicin—testicular cancer	0.00128	0.0043	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Bleomycin—testicular cancer	0.00128	0.00429	CcSEcCtD
Aminocaproic Acid—Oedema—Bleomycin—testicular cancer	0.00128	0.00429	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Etoposide—testicular cancer	0.00127	0.00424	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Doxorubicin—testicular cancer	0.00126	0.00421	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Bleomycin—testicular cancer	0.00126	0.00421	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Vinblastine—testicular cancer	0.00125	0.00419	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Doxorubicin—testicular cancer	0.00125	0.00419	CcSEcCtD
Aminocaproic Acid—Myalgia—Dactinomycin—testicular cancer	0.00125	0.00418	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Ifosfamide—testicular cancer	0.00125	0.00417	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Vinblastine—testicular cancer	0.00124	0.00416	CcSEcCtD
Aminocaproic Acid—Tinnitus—Cisplatin—testicular cancer	0.00124	0.00415	CcSEcCtD
Aminocaproic Acid—Discomfort—Dactinomycin—testicular cancer	0.00123	0.00413	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Chlorambucil—testicular cancer	0.00122	0.00409	CcSEcCtD
Aminocaproic Acid—Malaise—Ifosfamide—testicular cancer	0.00121	0.00406	CcSEcCtD
Aminocaproic Acid—PLG—amb2 Integrin signaling—MMP2—testicular cancer	0.0012	0.0758	CbGpPWpGaD
Aminocaproic Acid—PLAT—amb2 Integrin signaling—MMP2—testicular cancer	0.0012	0.0758	CbGpPWpGaD
Aminocaproic Acid—PLG—Activation of Matrix Metalloproteinases—MMP2—testicular cancer	0.0012	0.0758	CbGpPWpGaD
Aminocaproic Acid—Leukopenia—Ifosfamide—testicular cancer	0.0012	0.00403	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Vinblastine—testicular cancer	0.0012	0.00402	CcSEcCtD
Aminocaproic Acid—Hypotension—Bleomycin—testicular cancer	0.0012	0.00401	CcSEcCtD
Aminocaproic Acid—Oedema—Dactinomycin—testicular cancer	0.0012	0.00401	CcSEcCtD
Aminocaproic Acid—Blood urea increased—Doxorubicin—testicular cancer	0.00119	0.00398	CcSEcCtD
Aminocaproic Acid—Pruritus—Chlorambucil—testicular cancer	0.00117	0.00393	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Dactinomycin—testicular cancer	0.00117	0.00392	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00117	0.00391	CcSEcCtD
Aminocaproic Acid—Convulsion—Ifosfamide—testicular cancer	0.00116	0.0039	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Bleomycin—testicular cancer	0.00114	0.00383	CcSEcCtD
Aminocaproic Acid—Myalgia—Ifosfamide—testicular cancer	0.00114	0.00383	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Chlorambucil—testicular cancer	0.00113	0.0038	CcSEcCtD
Aminocaproic Acid—Discomfort—Ifosfamide—testicular cancer	0.00113	0.00378	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Vinblastine—testicular cancer	0.00112	0.00375	CcSEcCtD
Aminocaproic Acid—Confusional state—Ifosfamide—testicular cancer	0.00111	0.0037	CcSEcCtD
Aminocaproic Acid—Pain—Bleomycin—testicular cancer	0.0011	0.00367	CcSEcCtD
Aminocaproic Acid—Oedema—Ifosfamide—testicular cancer	0.0011	0.00367	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Ifosfamide—testicular cancer	0.0011	0.00367	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00109	0.00365	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00109	0.00365	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Methotrexate—testicular cancer	0.00108	0.00361	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Cisplatin—testicular cancer	0.00108	0.0036	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Ifosfamide—testicular cancer	0.00107	0.00359	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Bleomycin—testicular cancer	0.00106	0.00354	CcSEcCtD
Aminocaproic Acid—Vomiting—Chlorambucil—testicular cancer	0.00105	0.00353	CcSEcCtD
Aminocaproic Acid—Malaise—Cisplatin—testicular cancer	0.00104	0.0035	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Vinblastine—testicular cancer	0.00104	0.00348	CcSEcCtD
Aminocaproic Acid—Leukopenia—Cisplatin—testicular cancer	0.00104	0.00347	CcSEcCtD
Aminocaproic Acid—Hypotension—Ifosfamide—testicular cancer	0.00102	0.00343	CcSEcCtD
Aminocaproic Acid—Pain—Dactinomycin—testicular cancer	0.00102	0.00343	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00102	0.00342	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Epirubicin—testicular cancer	0.00101	0.00337	CcSEcCtD
Aminocaproic Acid—Dizziness—Vinblastine—testicular cancer	0.001	0.00336	CcSEcCtD
Aminocaproic Acid—Convulsion—Cisplatin—testicular cancer	0.001	0.00336	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000999	0.00334	CcSEcCtD
Aminocaproic Acid—Myalgia—Cisplatin—testicular cancer	0.000986	0.0033	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Dactinomycin—testicular cancer	0.000986	0.0033	CcSEcCtD
Aminocaproic Acid—Nausea—Chlorambucil—testicular cancer	0.000985	0.0033	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Etoposide—testicular cancer	0.000985	0.0033	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000979	0.00328	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Ifosfamide—testicular cancer	0.000978	0.00327	CcSEcCtD
Aminocaproic Acid—Discomfort—Cisplatin—testicular cancer	0.000975	0.00326	CcSEcCtD
Aminocaproic Acid—Vomiting—Vinblastine—testicular cancer	0.000966	0.00323	CcSEcCtD
Aminocaproic Acid—Malaise—Etoposide—testicular cancer	0.000957	0.0032	CcSEcCtD
Aminocaproic Acid—Headache—Vinblastine—testicular cancer	0.000952	0.00319	CcSEcCtD
Aminocaproic Acid—Leukopenia—Etoposide—testicular cancer	0.00095	0.00318	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Dactinomycin—testicular cancer	0.000946	0.00317	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Cisplatin—testicular cancer	0.000946	0.00316	CcSEcCtD
Aminocaproic Acid—Oedema—Cisplatin—testicular cancer	0.000946	0.00316	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Bleomycin—testicular cancer	0.000946	0.00316	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000945	0.00316	CcSEcCtD
Aminocaproic Acid—Pain—Ifosfamide—testicular cancer	0.000938	0.00314	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Etoposide—testicular cancer	0.000933	0.00312	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Doxorubicin—testicular cancer	0.000933	0.00312	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Cisplatin—testicular cancer	0.000926	0.0031	CcSEcCtD
Aminocaproic Acid—Convulsion—Etoposide—testicular cancer	0.00092	0.00308	CcSEcCtD
Aminocaproic Acid—Pruritus—Bleomycin—testicular cancer	0.000908	0.00304	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Ifosfamide—testicular cancer	0.000904	0.00302	CcSEcCtD
Aminocaproic Acid—Nausea—Vinblastine—testicular cancer	0.000903	0.00302	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000897	0.003	CcSEcCtD
Aminocaproic Acid—Discomfort—Etoposide—testicular cancer	0.000893	0.00299	CcSEcCtD
Aminocaproic Acid—Hypotension—Cisplatin—testicular cancer	0.000884	0.00296	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Dactinomycin—testicular cancer	0.000882	0.00295	CcSEcCtD
Aminocaproic Acid—Confusional state—Etoposide—testicular cancer	0.000873	0.00292	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Epirubicin—testicular cancer	0.000871	0.00292	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Ifosfamide—testicular cancer	0.000867	0.0029	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Etoposide—testicular cancer	0.000866	0.0029	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000862	0.00288	CcSEcCtD
Aminocaproic Acid—PLAT—Endochondral Ossification—FGFR3—testicular cancer	0.00085	0.0535	CbGpPWpGaD
Aminocaproic Acid—Thrombocytopenia—Etoposide—testicular cancer	0.000848	0.00284	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Cisplatin—testicular cancer	0.000843	0.00282	CcSEcCtD
Aminocaproic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MMP2—testicular cancer	0.000842	0.0531	CbGpPWpGaD
Aminocaproic Acid—Diarrhoea—Dactinomycin—testicular cancer	0.000819	0.00274	CcSEcCtD
Aminocaproic Acid—Vomiting—Bleomycin—testicular cancer	0.000816	0.00273	CcSEcCtD
Aminocaproic Acid—Hypotension—Etoposide—testicular cancer	0.000809	0.00271	CcSEcCtD
Aminocaproic Acid—Rash—Bleomycin—testicular cancer	0.000809	0.00271	CcSEcCtD
Aminocaproic Acid—Pain—Cisplatin—testicular cancer	0.000809	0.00271	CcSEcCtD
Aminocaproic Acid—Dermatitis—Bleomycin—testicular cancer	0.000808	0.00271	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Ifosfamide—testicular cancer	0.000808	0.0027	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Doxorubicin—testicular cancer	0.000806	0.0027	CcSEcCtD
Aminocaproic Acid—Renal failure—Methotrexate—testicular cancer	0.0008	0.00268	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Cisplatin—testicular cancer	0.000779	0.00261	CcSEcCtD
Aminocaproic Acid—Pruritus—Ifosfamide—testicular cancer	0.000776	0.0026	CcSEcCtD
Aminocaproic Acid—PLG—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000776	0.0489	CbGpPWpGaD
Aminocaproic Acid—PLAT—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000776	0.0489	CbGpPWpGaD
Aminocaproic Acid—Dyspnoea—Etoposide—testicular cancer	0.000772	0.00258	CcSEcCtD
Aminocaproic Acid—Nausea—Bleomycin—testicular cancer	0.000762	0.00255	CcSEcCtD
Aminocaproic Acid—Vomiting—Dactinomycin—testicular cancer	0.000761	0.00255	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Methotrexate—testicular cancer	0.000759	0.00254	CcSEcCtD
Aminocaproic Acid—Rash—Dactinomycin—testicular cancer	0.000755	0.00253	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Ifosfamide—testicular cancer	0.00075	0.00251	CcSEcCtD
Aminocaproic Acid—Renal failure—Epirubicin—testicular cancer	0.000748	0.0025	CcSEcCtD
Aminocaproic Acid—Pain—Etoposide—testicular cancer	0.000741	0.00248	CcSEcCtD
Aminocaproic Acid—Dizziness—Ifosfamide—testicular cancer	0.000725	0.00243	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Etoposide—testicular cancer	0.000714	0.00239	CcSEcCtD
Aminocaproic Acid—Nausea—Dactinomycin—testicular cancer	0.000711	0.00238	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Epirubicin—testicular cancer	0.000711	0.00238	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Etoposide—testicular cancer	0.000708	0.00237	CcSEcCtD
Aminocaproic Acid—Vomiting—Ifosfamide—testicular cancer	0.000697	0.00233	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Cisplatin—testicular cancer	0.000697	0.00233	CcSEcCtD
Aminocaproic Acid—Bradycardia—Epirubicin—testicular cancer	0.000696	0.00233	CcSEcCtD
Aminocaproic Acid—Renal failure—Doxorubicin—testicular cancer	0.000693	0.00232	CcSEcCtD
Aminocaproic Acid—Rash—Ifosfamide—testicular cancer	0.000692	0.00231	CcSEcCtD
Aminocaproic Acid—Dermatitis—Ifosfamide—testicular cancer	0.000691	0.00231	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Etoposide—testicular cancer	0.000685	0.00229	CcSEcCtD
Aminocaproic Acid—Tinnitus—Methotrexate—testicular cancer	0.000681	0.00228	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Doxorubicin—testicular cancer	0.000657	0.0022	CcSEcCtD
Aminocaproic Acid—Nausea—Ifosfamide—testicular cancer	0.000652	0.00218	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Cisplatin—testicular cancer	0.000647	0.00217	CcSEcCtD
Aminocaproic Acid—Bradycardia—Doxorubicin—testicular cancer	0.000644	0.00215	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Etoposide—testicular cancer	0.000638	0.00214	CcSEcCtD
Aminocaproic Acid—Tinnitus—Epirubicin—testicular cancer	0.000637	0.00213	CcSEcCtD
Aminocaproic Acid—Pruritus—Etoposide—testicular cancer	0.000613	0.00205	CcSEcCtD
Aminocaproic Acid—Vomiting—Cisplatin—testicular cancer	0.000601	0.00201	CcSEcCtD
Aminocaproic Acid—Rash—Cisplatin—testicular cancer	0.000596	0.002	CcSEcCtD
Aminocaproic Acid—Dermatitis—Cisplatin—testicular cancer	0.000596	0.00199	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Etoposide—testicular cancer	0.000593	0.00198	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Methotrexate—testicular cancer	0.00059	0.00197	CcSEcCtD
Aminocaproic Acid—Tinnitus—Doxorubicin—testicular cancer	0.00059	0.00197	CcSEcCtD
Aminocaproic Acid—Malaise—Methotrexate—testicular cancer	0.000573	0.00192	CcSEcCtD
Aminocaproic Acid—Dizziness—Etoposide—testicular cancer	0.000573	0.00192	CcSEcCtD
Aminocaproic Acid—Leukopenia—Methotrexate—testicular cancer	0.000569	0.0019	CcSEcCtD
Aminocaproic Acid—Nausea—Cisplatin—testicular cancer	0.000562	0.00188	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Epirubicin—testicular cancer	0.000552	0.00185	CcSEcCtD
Aminocaproic Acid—Convulsion—Methotrexate—testicular cancer	0.000551	0.00184	CcSEcCtD
Aminocaproic Acid—Vomiting—Etoposide—testicular cancer	0.000551	0.00184	CcSEcCtD
Aminocaproic Acid—Rash—Etoposide—testicular cancer	0.000546	0.00183	CcSEcCtD
Aminocaproic Acid—Dermatitis—Etoposide—testicular cancer	0.000546	0.00183	CcSEcCtD
Aminocaproic Acid—Headache—Etoposide—testicular cancer	0.000543	0.00182	CcSEcCtD
Aminocaproic Acid—Myalgia—Methotrexate—testicular cancer	0.000541	0.00181	CcSEcCtD
Aminocaproic Acid—Malaise—Epirubicin—testicular cancer	0.000537	0.0018	CcSEcCtD
Aminocaproic Acid—Discomfort—Methotrexate—testicular cancer	0.000535	0.00179	CcSEcCtD
Aminocaproic Acid—Syncope—Epirubicin—testicular cancer	0.000534	0.00179	CcSEcCtD
Aminocaproic Acid—Leukopenia—Epirubicin—testicular cancer	0.000533	0.00178	CcSEcCtD
Aminocaproic Acid—PLG—Degradation of the extracellular matrix—MMP2—testicular cancer	0.000531	0.0334	CbGpPWpGaD
Aminocaproic Acid—Confusional state—Methotrexate—testicular cancer	0.000523	0.00175	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Epirubicin—testicular cancer	0.000523	0.00175	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Methotrexate—testicular cancer	0.000519	0.00174	CcSEcCtD
Aminocaproic Acid—Convulsion—Epirubicin—testicular cancer	0.000516	0.00173	CcSEcCtD
Aminocaproic Acid—Nausea—Etoposide—testicular cancer	0.000515	0.00172	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Doxorubicin—testicular cancer	0.000511	0.00171	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Methotrexate—testicular cancer	0.000508	0.0017	CcSEcCtD
Aminocaproic Acid—Myalgia—Epirubicin—testicular cancer	0.000507	0.0017	CcSEcCtD
Aminocaproic Acid—Discomfort—Epirubicin—testicular cancer	0.0005	0.00167	CcSEcCtD
Aminocaproic Acid—Malaise—Doxorubicin—testicular cancer	0.000496	0.00166	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—KITLG—testicular cancer	0.000496	0.0312	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—KITLG—testicular cancer	0.000496	0.0312	CbGpPWpGaD
Aminocaproic Acid—Syncope—Doxorubicin—testicular cancer	0.000494	0.00165	CcSEcCtD
Aminocaproic Acid—Leukopenia—Doxorubicin—testicular cancer	0.000493	0.00165	CcSEcCtD
Aminocaproic Acid—Confusional state—Epirubicin—testicular cancer	0.00049	0.00164	CcSEcCtD
Aminocaproic Acid—Oedema—Epirubicin—testicular cancer	0.000486	0.00163	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Epirubicin—testicular cancer	0.000486	0.00163	CcSEcCtD
Aminocaproic Acid—Hypotension—Methotrexate—testicular cancer	0.000485	0.00162	CcSEcCtD
Aminocaproic Acid—Loss of consciousness—Doxorubicin—testicular cancer	0.000484	0.00162	CcSEcCtD
Aminocaproic Acid—Shock—Epirubicin—testicular cancer	0.000478	0.0016	CcSEcCtD
Aminocaproic Acid—Convulsion—Doxorubicin—testicular cancer	0.000477	0.0016	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Epirubicin—testicular cancer	0.000475	0.00159	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000473	0.00158	CcSEcCtD
Aminocaproic Acid—Myalgia—Doxorubicin—testicular cancer	0.000469	0.00157	CcSEcCtD
Aminocaproic Acid—Discomfort—Doxorubicin—testicular cancer	0.000463	0.00155	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Methotrexate—testicular cancer	0.000463	0.00155	CcSEcCtD
Aminocaproic Acid—Hypotension—Epirubicin—testicular cancer	0.000454	0.00152	CcSEcCtD
Aminocaproic Acid—Confusional state—Doxorubicin—testicular cancer	0.000453	0.00152	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Doxorubicin—testicular cancer	0.000449	0.0015	CcSEcCtD
Aminocaproic Acid—Oedema—Doxorubicin—testicular cancer	0.000449	0.0015	CcSEcCtD
Aminocaproic Acid—Pain—Methotrexate—testicular cancer	0.000444	0.00148	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000442	0.00148	CcSEcCtD
Aminocaproic Acid—Shock—Doxorubicin—testicular cancer	0.000442	0.00148	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Doxorubicin—testicular cancer	0.00044	0.00147	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Epirubicin—testicular cancer	0.000433	0.00145	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Methotrexate—testicular cancer	0.000428	0.00143	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Methotrexate—testicular cancer	0.000424	0.00142	CcSEcCtD
Aminocaproic Acid—Hypotension—Doxorubicin—testicular cancer	0.00042	0.00141	CcSEcCtD
Aminocaproic Acid—Pain—Epirubicin—testicular cancer	0.000415	0.00139	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Methotrexate—testicular cancer	0.00041	0.00137	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000409	0.00137	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Doxorubicin—testicular cancer	0.000401	0.00134	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Epirubicin—testicular cancer	0.0004	0.00134	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Epirubicin—testicular cancer	0.000397	0.00133	CcSEcCtD
Aminocaproic Acid—Pain—Doxorubicin—testicular cancer	0.000384	0.00129	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Epirubicin—testicular cancer	0.000384	0.00128	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Methotrexate—testicular cancer	0.000382	0.00128	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Doxorubicin—testicular cancer	0.00037	0.00124	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling by PDGF—FGFR3—testicular cancer	0.000368	0.0232	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling by PDGF—FGFR3—testicular cancer	0.000368	0.0232	CbGpPWpGaD
Aminocaproic Acid—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000367	0.00123	CcSEcCtD
Aminocaproic Acid—Pruritus—Methotrexate—testicular cancer	0.000367	0.00123	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Epirubicin—testicular cancer	0.000358	0.0012	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Doxorubicin—testicular cancer	0.000355	0.00119	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Methotrexate—testicular cancer	0.000355	0.00119	CcSEcCtD
Aminocaproic Acid—Pruritus—Epirubicin—testicular cancer	0.000344	0.00115	CcSEcCtD
Aminocaproic Acid—Dizziness—Methotrexate—testicular cancer	0.000343	0.00115	CcSEcCtD
Aminocaproic Acid—PLG—Signaling by PDGF—KIT—testicular cancer	0.000338	0.0213	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling by PDGF—KIT—testicular cancer	0.000338	0.0213	CbGpPWpGaD
Aminocaproic Acid—Diarrhoea—Epirubicin—testicular cancer	0.000332	0.00111	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Doxorubicin—testicular cancer	0.000331	0.00111	CcSEcCtD
Aminocaproic Acid—Vomiting—Methotrexate—testicular cancer	0.00033	0.0011	CcSEcCtD
Aminocaproic Acid—Rash—Methotrexate—testicular cancer	0.000327	0.00109	CcSEcCtD
Aminocaproic Acid—Dermatitis—Methotrexate—testicular cancer	0.000327	0.00109	CcSEcCtD
Aminocaproic Acid—Headache—Methotrexate—testicular cancer	0.000325	0.00109	CcSEcCtD
Aminocaproic Acid—Dizziness—Epirubicin—testicular cancer	0.000321	0.00107	CcSEcCtD
Aminocaproic Acid—Pruritus—Doxorubicin—testicular cancer	0.000318	0.00106	CcSEcCtD
Aminocaproic Acid—Vomiting—Epirubicin—testicular cancer	0.000309	0.00103	CcSEcCtD
Aminocaproic Acid—Nausea—Methotrexate—testicular cancer	0.000308	0.00103	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Doxorubicin—testicular cancer	0.000307	0.00103	CcSEcCtD
Aminocaproic Acid—Rash—Epirubicin—testicular cancer	0.000306	0.00102	CcSEcCtD
Aminocaproic Acid—Dermatitis—Epirubicin—testicular cancer	0.000306	0.00102	CcSEcCtD
Aminocaproic Acid—Headache—Epirubicin—testicular cancer	0.000304	0.00102	CcSEcCtD
Aminocaproic Acid—Dizziness—Doxorubicin—testicular cancer	0.000297	0.000994	CcSEcCtD
Aminocaproic Acid—Nausea—Epirubicin—testicular cancer	0.000288	0.000965	CcSEcCtD
Aminocaproic Acid—Vomiting—Doxorubicin—testicular cancer	0.000286	0.000956	CcSEcCtD
Aminocaproic Acid—Rash—Doxorubicin—testicular cancer	0.000283	0.000948	CcSEcCtD
Aminocaproic Acid—Dermatitis—Doxorubicin—testicular cancer	0.000283	0.000947	CcSEcCtD
Aminocaproic Acid—Headache—Doxorubicin—testicular cancer	0.000281	0.000942	CcSEcCtD
Aminocaproic Acid—Nausea—Doxorubicin—testicular cancer	0.000267	0.000893	CcSEcCtD
Aminocaproic Acid—PLAT—Signaling Pathways—INSL3—testicular cancer	0.000252	0.0159	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—INSL3—testicular cancer	0.000252	0.0159	CbGpPWpGaD
Aminocaproic Acid—PLG—Extracellular matrix organization—MMP2—testicular cancer	0.000223	0.014	CbGpPWpGaD
Aminocaproic Acid—PLG—Metabolism of proteins—MMP2—testicular cancer	0.000104	0.00655	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—HPGDS—testicular cancer	9.64e-05	0.00607	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—H2AFZ—testicular cancer	8.41e-05	0.0053	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—H2AFZ—testicular cancer	8.06e-05	0.00508	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—H2AFZ—testicular cancer	8.06e-05	0.00508	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—STK11—testicular cancer	8.01e-05	0.00505	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—STK11—testicular cancer	8.01e-05	0.00505	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—KITLG—testicular cancer	7.74e-05	0.00488	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—KITLG—testicular cancer	7.41e-05	0.00467	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—KITLG—testicular cancer	7.41e-05	0.00467	CbGpPWpGaD
Aminocaproic Acid—AOX1—Metabolism—STK11—testicular cancer	7.01e-05	0.00441	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—FGFR3—testicular cancer	5.75e-05	0.00362	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—FGFR3—testicular cancer	5.51e-05	0.00347	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—FGFR3—testicular cancer	5.51e-05	0.00347	CbGpPWpGaD
Aminocaproic Acid—AOX1—Disease—KIT—testicular cancer	5.28e-05	0.00333	CbGpPWpGaD
Aminocaproic Acid—PLG—Signaling Pathways—KIT—testicular cancer	5.06e-05	0.00319	CbGpPWpGaD
Aminocaproic Acid—PLAT—Signaling Pathways—KIT—testicular cancer	5.06e-05	0.00319	CbGpPWpGaD
